JP2020533604A5 - - Google Patents

Download PDF

Info

Publication number
JP2020533604A5
JP2020533604A5 JP2020515677A JP2020515677A JP2020533604A5 JP 2020533604 A5 JP2020533604 A5 JP 2020533604A5 JP 2020515677 A JP2020515677 A JP 2020515677A JP 2020515677 A JP2020515677 A JP 2020515677A JP 2020533604 A5 JP2020533604 A5 JP 2020533604A5
Authority
JP
Japan
Prior art keywords
sample
fragments
level
proadm
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020515677A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020533604A (ja
JP7329503B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2018/074722 external-priority patent/WO2019053115A1/en
Publication of JP2020533604A publication Critical patent/JP2020533604A/ja
Publication of JP2020533604A5 publication Critical patent/JP2020533604A5/ja
Priority to JP2023006500A priority Critical patent/JP7544879B2/ja
Application granted granted Critical
Publication of JP7329503B2 publication Critical patent/JP7329503B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020515677A 2017-09-13 2018-09-13 重篤患者用の療法モニタリングマーカーとしてのpro-adm Active JP7329503B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023006500A JP7544879B2 (ja) 2017-09-13 2023-01-19 重篤患者用の療法モニタリングマーカーとしてのpro-adm

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17190912.0 2017-09-13
EP17190912 2017-09-13
PCT/EP2018/074722 WO2019053115A1 (en) 2017-09-13 2018-09-13 USE OF PROADM AS A THERAPEUTIC SURVEILLANCE MARKER FOR CRITICALLY PHASE PATIENTS

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023006500A Division JP7544879B2 (ja) 2017-09-13 2023-01-19 重篤患者用の療法モニタリングマーカーとしてのpro-adm

Publications (3)

Publication Number Publication Date
JP2020533604A JP2020533604A (ja) 2020-11-19
JP2020533604A5 true JP2020533604A5 (https=) 2021-03-25
JP7329503B2 JP7329503B2 (ja) 2023-08-18

Family

ID=59887050

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2020515677A Active JP7329503B2 (ja) 2017-09-13 2018-09-13 重篤患者用の療法モニタリングマーカーとしてのpro-adm
JP2020515760A Active JP7366007B2 (ja) 2017-09-13 2018-09-13 プロアドレノメジュリンに基づく輸液療法のガイダンスのための方法
JP2023006500A Active JP7544879B2 (ja) 2017-09-13 2023-01-19 重篤患者用の療法モニタリングマーカーとしてのpro-adm
JP2023175415A Abandoned JP2023181226A (ja) 2017-09-13 2023-10-10 プロアドレノメジュリンに基づく輸液療法のガイダンスのための方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2020515760A Active JP7366007B2 (ja) 2017-09-13 2018-09-13 プロアドレノメジュリンに基づく輸液療法のガイダンスのための方法
JP2023006500A Active JP7544879B2 (ja) 2017-09-13 2023-01-19 重篤患者用の療法モニタリングマーカーとしてのpro-adm
JP2023175415A Abandoned JP2023181226A (ja) 2017-09-13 2023-10-10 プロアドレノメジュリンに基づく輸液療法のガイダンスのための方法

Country Status (7)

Country Link
US (3) US20200300864A1 (https=)
EP (2) EP3682245A1 (https=)
JP (4) JP7329503B2 (https=)
CN (2) CN111065927B (https=)
BR (1) BR112020004138A2 (https=)
CA (1) CA3075440A1 (https=)
WO (2) WO2019053116A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026013199A1 (en) 2024-07-12 2026-01-15 Cezanne S.A.S. Clinical immunoassay with early signal measurement
CN118976116B (zh) * 2024-10-22 2025-01-24 四川大学华西医院 琥珀酰明胶在制备腹膜透析液中的用途以及一种含琥珀酰明胶、枸橼酸钠的腹膜透析液

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2570703B1 (fr) 1984-09-26 1988-07-08 Commissariat Energie Atomique Complexes macropolycycliques de terres rares et application a titre de marqueurs fluorescents
US4882733A (en) 1987-03-13 1989-11-21 Ford Aerospace Corporation Method and apparatus for combining encoding and modulation
FR2664699B1 (fr) 1990-07-13 1995-08-18 Cis Bio Int Procede d'amplification du signal d'emission d'un compose luminescent.
DE69602756T2 (de) 1995-08-18 2000-02-10 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Rockville Funktionelle rolle von adrenomedullin(am) und dem gen-verwandten produkt(pamp) in der menschlichen pathologie und physiologie
KR100425525B1 (ko) 2000-11-21 2004-03-30 재단법인서울대학교산학협력재단 조산과 태아감염 및 태아손상을 산전 진단하기 위한진단시약 및 진단키트
US6864237B2 (en) * 2002-05-17 2005-03-08 Ping Wang Treatment of shock using adrenomedullin and adrenomedullin binding protein-1
DE10316583A1 (de) 2003-04-10 2004-10-28 B.R.A.H.M.S Aktiengesellschaft Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung
CN101208602A (zh) * 2005-04-15 2008-06-25 贝克顿迪金森公司 脓毒症的诊断
DE102006034142A1 (de) * 2006-07-24 2008-01-31 B.R.A.H.M.S. Aktiengesellschaft Verfahren zur Steuerung der Therapie von Patienten mit Herzinsuffizienz anhand der vitro Bestimmung von Schwellenwerten von vasoaktiven Peptiden
US9012151B2 (en) * 2006-11-09 2015-04-21 B.R.A.H.M.S. Gmbh Methods of diagnosis and risk stratification of adverse events in post myocardial infarction patients using pro-adrenomedullin
DE102006060112A1 (de) 2006-12-20 2008-06-26 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM
US8298774B2 (en) 2007-03-12 2012-10-30 Biomedica Medizinprodukte Gmbh & Co Kg Diagnosis of septic complications
PL2185937T5 (pl) 2007-09-07 2014-12-31 Univ Zuerich Sposób wykrywania posocznicy u ludzi
ES2486268T3 (es) 2007-11-16 2014-08-18 Biocartis Nv Biomarcadores y procedimientos de diagnóstico, predicción y/o pronóstico de septicemia y usos de los mismos
JP5989965B2 (ja) * 2008-01-08 2016-09-07 メルク シャープ エンド ドーム リミテッド 2−{4−[(3s)−ピペリジン−3−イル]フェニル}−2h−インダゾール−7−カルボキサミドの薬学的に許容される塩
EP2131200A1 (en) * 2008-06-04 2009-12-09 BRAHMS Aktiengesellschaft A marker for graft failure and mortality
US9229013B2 (en) 2009-05-05 2016-01-05 B.R.A.H.M.S Gmbh Vasoactive hormone-based stratification of patients suffering from diseases related to endothelial function/dysfunction
JP5702371B2 (ja) * 2009-05-27 2015-04-15 デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド Muc1のアンタゴニストを使用した、炎症の阻害
EP2438447B1 (en) 2009-06-05 2015-02-18 B.R.A.H.M.S GmbH Detection of bacterial infections in subjects suffering from dyspnea.
US8383332B2 (en) 2009-10-13 2013-02-26 B.R.A.H.M.S. Gmbh Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack
EP2545379B1 (en) 2010-03-08 2015-09-30 B.R.A.H.M.S GmbH Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with non-specific complaints
WO2012059477A1 (en) 2010-11-01 2012-05-10 B.R.A.H.M.S Gmbh Prognosis and risk assessment of patients with non-specific complaints
SG11201402362VA (en) * 2011-11-16 2014-06-27 Adrenomed Ag Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition
CA2856150A1 (en) * 2011-11-16 2013-05-23 Adrenomed Ag Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease
US11067586B2 (en) * 2011-11-16 2021-07-20 Sphingotec Gmbh Adrenomedullin assays and methods for determining mature adrenomedullin
DK2780717T3 (en) * 2011-11-16 2017-02-13 Sphingotec Gmbh ADRENOMEDULLINASSAYS AND METHODS FOR DETERMINING MODERN ADRENOMEDULLIN
US10935548B2 (en) 2011-12-08 2021-03-02 Astute Medical, Inc. Methods for diagnosis and prognosis of renal injury and renal failure using insulin-like growth factor-binding protein 7 and metalloproteinase inhibitor 2
EP2637023A1 (en) * 2012-03-08 2013-09-11 B.R.A.H.M.S GmbH Prediction of outcome in patients with chronic obstructive pulmonary disease
EP2976646B1 (en) * 2013-03-20 2020-08-19 sphingotec GmbH Adrenomedullin to guide therapy of blood pressure decline
US9597730B2 (en) * 2013-04-19 2017-03-21 United Technologies Corporation Build plate and apparatus for additive manufacturing
US20180348235A1 (en) 2015-11-27 2018-12-06 B.R.A.H.M.S Gmbh MR-proADM as marker for the extracellular volume status of a subject
EP4231018A3 (en) 2016-07-08 2023-11-15 SphingoTec GmbH Adrenomedullin for assessing congestion in a subject with acute heart failure
CA3033094A1 (en) 2016-08-09 2018-02-15 B.R.A.H.M.S Gmbh Histones and/or proadm as markers indicating an adverse event

Similar Documents

Publication Publication Date Title
Viguier et al. High frequency of cholestasis in generalized pustular psoriasis: evidence for neutrophilic involvement of the biliary tract
JP6106277B2 (ja) 尿中エキソソームmRNAおよびそれを用いて糖尿病性腎症を検出する方法
Klingele et al. Elevated procalcitonin in patients after cardiac surgery: a hint to nonocclusive mesenteric ischemia
JP2015504519A5 (https=)
JP2020533604A5 (https=)
JP2021534385A5 (https=)
RU2674252C2 (ru) Способ прогнозирования тяжести течения и исхода заболевания у пациентов с хирургическим сепсисом
JP2023041741A5 (https=)
Behl et al. Death during hospitalization in patients on chronic hemodialysis
Mularek-Kubzdela et al. Lung transplantation in patients with pulmonary arterial hypertension: The opinion of the Polish Cardiac Society Working Group on Pulmonary Circulation
RU2799822C1 (ru) Способ выявления высокого риска антибиотикорезистентности у пациентов с мочекаменной болезнью при инфекции мочевыводящих путей
WO2017068347A1 (en) Detection of bacterial infection
RU2633077C1 (ru) Способ прогнозирования увеличения объема поражения легочной ткани при инфильтративном туберкулезе
RU2020111719A (ru) Про-адм в качестве маркера мониторинга терапии для критически больных пациентов
JP2019528706A (ja) 冠動脈疾患の血中rnaバイオマーカー
Soyler et al. Differentiation of acute decompensated heart failure and pneumonia in emergency department
Lou et al. Salmonella Typhi infective endocarditis combined with multiorgan infection in an elderly woman-A case report and literature review
JPWO2021204770A5 (https=)
Poopipatpab et al. The incidence, characteristics and outcomes of pneumothorax in Thai surgical intensive care units (Thai-SICU study)
Ray et al. A Clinicopathological Study of Necrotizing Pancreatitis with Special Emphasis on Need for Surgery and Its Outcome.
Japar et al. 19 Prevalence and Characteristics of Patients with Intradialytic Hypertension in Indonesia
Lezaic Long-Term Impact Of Sars-Cov-2 Infection On The Progression Of Chronic Kidney Disease: Retrospective Study Of A National Multicenter Cohort
Asif et al. CT Diagnosis of Terminal Ileitis with Clinical, Endoscopic, and Histologic Correlation-More Than Just IBD: 1153
RU2669401C1 (ru) Способ прогнозирования возникновения повторной внебольничной пневмонии у мужчин молодого возраста
HK40106399A (zh) 用於管理抗生素施用的方法